logo-loader

Dominion Petroleum One2One Investor Presentation 14 May 2009

Published: 19:00 13 May 2009 EDT

no_picture_pai

Rob Shepherd of Dominion Petroleum updates investors at the Proactiveinvestors One2One Forum on 14 May 2009

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

1 hour, 42 minutes ago